Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Q: What does CUSIP 98943L107 represent in this 13F holders report?

CUSIP 98943L107 is the security identifier for ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in Q3 2020?

65 institutional investors reported ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 98943L107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock,$0.001 par value per share
Shares outstanding: 72,096,078
Total 13F shares: 31,635,340
Share change: +5,220,005
Total reported value: $1,033,195,545
Price per share: $32.69
Number of holders: 65
Value change: +$169,604,096
Number of buys: 43
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 98943L107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VIKING GLOBAL INVESTORS LP	13F	Company	6.2%	4,443,284	$213,366,000	—	30 Jun 2020	13F
Matrix Capital Management Company, LP	13F	Company	5.3%	3,821,739	$183,520,000	—	30 Jun 2020	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	3.7%	2,664,409	$127,945,000	—	30 Jun 2020	13F
FMR LLC	13F	Company	3.2%	2,310,946	$110,972,000	—	30 Jun 2020	13F
Redmile Group, LLC	13F	Company	2.3%	1,661,205	$79,771,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	2.2%	1,560,687	$74,944,000	—	30 Jun 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.6%	1,187,566	$57,027,000	—	30 Jun 2020	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	1.4%	991,174	$47,596,000	—	30 Jun 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.5%	1,050,003	$45,783,000	—	30 Jun 2020	13F
BlackRock Finance, Inc.	13F	Company	1.3%	912,549	$43,821,000	—	30 Jun 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.3%	914,705	$42,496,000	—	30 Jun 2020	13F
VANGUARD GROUP INC	13F	Company	1.1%	826,942	$39,709,000	—	30 Jun 2020	13F
Avidity Partners Management LP	13F	Company	0.94%	674,487	$32,389,000	—	30 Jun 2020	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.92%	659,950	$31,691,000	—	30 Jun 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.69%	498,272	$23,927,000	—	30 Jun 2020	13F
Capital World Investors	13F	Company	0.62%	450,000	$21,609,000	—	30 Jun 2020	13F
Mayo Clinic	13F	Company	0.61%	442,713	$21,259,000	—	30 Jun 2020	13F
Invesco Ltd.	13F	Company	0.38%	277,393	$13,320,000	—	30 Jun 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.23%	162,335	$7,795,000	—	30 Jun 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.24%	175,050	$7,380,000	—	30 Jun 2020	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.2%	144,200	$6,924,000	—	30 Jun 2020	13F
STATE STREET CORP	13F	Company	0.19%	137,270	$6,592,000	—	30 Jun 2020	13F
NORTHERN TRUST CORP	13F	Company	0.18%	132,536	$6,364,000	—	30 Jun 2020	13F
AXA S.A.	13F	Company	0.15%	106,643	$5,121,000	—	30 Jun 2020	13F
Artal Group S.A.	13F	Company	0.13%	92,000	$4,418,000	—	30 Jun 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	65,805	$3,160,000	—	30 Jun 2020	13F
Marshall Wace North America L.P.	13F	Company	0.08%	59,629	$2,863,000	—	30 Jun 2020	13F
Zimmer Partners, LP	13F	Company	0.08%	55,000	$2,641,000	—	30 Jun 2020	13F
Woodline Partners LP	13F	Company	0.06%	43,726	$2,100,000	—	30 Jun 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.06%	40,464	$1,943,000	—	30 Jun 2020	13F
Bank of New York Mellon Corp	13F	Company	0.04%	31,161	$1,496,000	—	30 Jun 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.03%	25,000	$1,201,000	—	30 Jun 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.03%	24,935	$1,197,000	—	30 Jun 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	22,859	$1,098,000	—	30 Jun 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	22,493	$1,080,000	—	30 Jun 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	16,939	$814,000	—	30 Jun 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	16,500	$792,000	—	30 Jun 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	15,587	$748,000	—	30 Jun 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	13,820	$664,000	—	30 Jun 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	13,141	$631,000	—	30 Jun 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	12,994	$624,000	—	30 Jun 2020	13F
MetLife Investment Management, LLC	13F	Company	0.01%	10,154	$487,595	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.01%	10,125	$486,000	—	30 Jun 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	9,500	$456,000	—	30 Jun 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	6,323	$304,000	—	30 Jun 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	5,935	$270,000	—	30 Jun 2020	13F
SG Americas Securities, LLC	13F	Company	0.01%	5,597	$269,000	—	30 Jun 2020	13F
CNA FINANCIAL CORP	13F	Company	0.01%	5,426	$261,000	—	30 Jun 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,245	$252,000	—	30 Jun 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	5,236	$252,000	—	30 Jun 2020	13F

Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q3 2020

As of 30 Sep 2020, Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,635,340 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Matrix Capital Management Company, LP, FMR LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, Redmile Group, LLC, CITADEL ADVISORS LLC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, and PERCEPTIVE ADVISORS LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.